|
Re: promised Oct 13th update confirmed?
|
3
|
Resverlogix Corp.
|
Oct 03, 2016 04:53PM
|
|
Re: Private placement one million plus units for US$2, half wt exercisable at US3, good for 3 years
|
4
|
Zenith Epigenetics
|
Mar 16, 2020 06:38PM
|
|
Re: Private placement one million plus units for US$2, half wt exercisable at US3, good for 3 years
|
3
|
Zenith Epigenetics
|
Mar 16, 2020 09:26PM
|
|
Re: Priceless on I.V. Regarding Zenith
|
6
|
Zenith Epigenetics
|
Apr 09, 2017 12:03PM
|
|
Re: Pre-market matching bids!! $1.81 !!!
|
1
|
Resverlogix Corp.
|
Jan 10, 2018 09:06AM
|
|
Re: Pre IPO?!!
|
5
|
Zenith Epigenetics
|
Dec 13, 2017 03:30PM
|
|
Re: Potential Scope of Indications for Apabetalone (selective BRD/BD inhibition)
|
1
|
Resverlogix Corp.
|
Nov 14, 2022 04:57PM
|
|
Re: Potential Scope of Indications for Apabetalone (selective BRD/BD inhibition)
|
4
|
Resverlogix Corp.
|
Nov 14, 2022 06:12PM
|
|
Re: Positives vs. negatives
|
6
|
Resverlogix Corp.
|
Nov 20, 2019 03:16PM
|
|
Re: Positive data on cognition already 'baked in'?
|
3
|
Resverlogix Corp.
|
Dec 03, 2019 10:55AM
|
|
Re: Positive data on cognition already 'baked in'?
|
2
|
Resverlogix Corp.
|
Dec 03, 2019 11:49AM
|
|
Re: Positive data on cognition already 'baked in'?
|
3
|
Resverlogix Corp.
|
Dec 03, 2019 12:09PM
|
|
Re: Phase 1b/2 trial expected to initiate 1Q 2019
|
3
|
Zenith Epigenetics
|
Mar 13, 2019 09:23AM
|
|
Re: Pfizer lays out ambitious vision for cancer portfolio in bid to reinvigorate its business.
|
9
|
Zenith Epigenetics
|
Mar 02, 2024 08:33AM
|
|
Re: Pfizer
|
7
|
Zenith Epigenetics
|
Mar 12, 2024 04:21PM
|
|
Re: Pfizer
|
5
|
Zenith Epigenetics
|
Jun 05, 2020 03:48PM
|
|
Re: Pfizer
|
5
|
Zenith Epigenetics
|
Jun 03, 2020 12:27PM
|
|
Re: Paris
|
1
|
Resverlogix Corp.
|
May 21, 2017 06:24PM
|
|
Re: OUCH!!! Things Move Faster In The Cancer Arena and Other Gems
|
3
|
Zenith Epigenetics
|
Sep 17, 2020 02:13PM
|
|
Re: OUCH!!! Things Move Faster In The Cancer Arena and Other Gems
|
3
|
Zenith Epigenetics
|
Sep 17, 2020 02:59PM
|
